Deciphering amyotrophic lateral sclerosis

What phenotype, neuropathology and genetics are telling us about pathogenesis

John Ravits, Stanley Appel, Robert H. Baloh, Richard Barohn, Benjamin Rix Brooks, Lauren Elman, Mary Kay Floeter, Christopher Henderson, Catherine Lomen-Hoerth, Jeffrey D. MacKlis, Leo McCluskey, Hiroshi Mitsumoto, Serge Przedborski, Jeffrey D Rothstein, John Q. Trojanowski, Leonard H. Van Den Berg, Steven Ringel

Research output: Contribution to journalArticle

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized phenotypically by progressive weakness and neuropathologically by loss of motor neurons. Phenotypically, there is marked heterogeneity. Typical ALS has mixed upper motor neuron (UMN) and lower motor neuron (LMN) involvement. Primary lateral sclerosis has predominant UMN involvement. Progressive muscular atrophy has predominant LMN involvement. Bulbar and limb ALS have predominant regional involvement. Frontotemporal dementia has significant cognitive and behavioral involvement. These phenotypes can be so distinctive that they would seem to have differing biology. However, they cannot be distinguished, at least neuropathologically or genetically. In sporadic ALS (SALS), they are mostly characterized by ubiquitinated cytoplasmic inclusions of TDP-43. In familial ALS (FALS), where phenotypes are indistinguishable from SALS and similarly heterogeneous, each mutated gene has its own genetic and molecular signature. Overall, since the same phenotypes can have multiple causes including different gene mutations, there must be multiple molecular mechanisms causing ALS - and ALS is a syndrome. Since, however, multiple phenotypes can be caused by one single gene mutation, a single molecular mechanism can cause heterogeneity. What the mechanisms are remain unknown, but active propagation of the pathology neuroanatomically seems to be a principal component. Leading candidate mechanisms include RNA processing, cell-cell interactions between neurons and non-neuronal neighbors, focal seeding from a misfolded protein that has prion-like propagation, and fatal errors introduced during neurodevelopment of the motor system. If fundamental mechanisms could be identified and understood, ALS therapy could rationally target progression and stop the disease - a goal that seems increasingly achievable.

Original languageEnglish (US)
Pages (from-to)5-18
Number of pages14
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume14
Issue numberSUPPL1
DOIs
StatePublished - May 2013

Fingerprint

Amyotrophic Lateral Sclerosis
Motor Neurons
Phenotype
Genes
Spinal Muscular Atrophy
Frontotemporal Dementia
Motor Neuron Disease
Mutation
Inclusion Bodies
Cell Communication
Disease Progression
Neuropathology
Molecular Biology
Extremities
RNA
Pathology
Neurons

Keywords

  • ALS
  • FTD
  • Motor neuron disease
  • PLS
  • PMA

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Deciphering amyotrophic lateral sclerosis : What phenotype, neuropathology and genetics are telling us about pathogenesis. / Ravits, John; Appel, Stanley; Baloh, Robert H.; Barohn, Richard; Rix Brooks, Benjamin; Elman, Lauren; Floeter, Mary Kay; Henderson, Christopher; Lomen-Hoerth, Catherine; MacKlis, Jeffrey D.; McCluskey, Leo; Mitsumoto, Hiroshi; Przedborski, Serge; Rothstein, Jeffrey D; Trojanowski, John Q.; Van Den Berg, Leonard H.; Ringel, Steven.

In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 14, No. SUPPL1, 05.2013, p. 5-18.

Research output: Contribution to journalArticle

Ravits, J, Appel, S, Baloh, RH, Barohn, R, Rix Brooks, B, Elman, L, Floeter, MK, Henderson, C, Lomen-Hoerth, C, MacKlis, JD, McCluskey, L, Mitsumoto, H, Przedborski, S, Rothstein, JD, Trojanowski, JQ, Van Den Berg, LH & Ringel, S 2013, 'Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 14, no. SUPPL1, pp. 5-18. https://doi.org/10.3109/21678421.2013.778548
Ravits, John ; Appel, Stanley ; Baloh, Robert H. ; Barohn, Richard ; Rix Brooks, Benjamin ; Elman, Lauren ; Floeter, Mary Kay ; Henderson, Christopher ; Lomen-Hoerth, Catherine ; MacKlis, Jeffrey D. ; McCluskey, Leo ; Mitsumoto, Hiroshi ; Przedborski, Serge ; Rothstein, Jeffrey D ; Trojanowski, John Q. ; Van Den Berg, Leonard H. ; Ringel, Steven. / Deciphering amyotrophic lateral sclerosis : What phenotype, neuropathology and genetics are telling us about pathogenesis. In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2013 ; Vol. 14, No. SUPPL1. pp. 5-18.
@article{6f76781270c4488a929fa72c317da1c2,
title = "Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis",
abstract = "Amyotrophic lateral sclerosis (ALS) is characterized phenotypically by progressive weakness and neuropathologically by loss of motor neurons. Phenotypically, there is marked heterogeneity. Typical ALS has mixed upper motor neuron (UMN) and lower motor neuron (LMN) involvement. Primary lateral sclerosis has predominant UMN involvement. Progressive muscular atrophy has predominant LMN involvement. Bulbar and limb ALS have predominant regional involvement. Frontotemporal dementia has significant cognitive and behavioral involvement. These phenotypes can be so distinctive that they would seem to have differing biology. However, they cannot be distinguished, at least neuropathologically or genetically. In sporadic ALS (SALS), they are mostly characterized by ubiquitinated cytoplasmic inclusions of TDP-43. In familial ALS (FALS), where phenotypes are indistinguishable from SALS and similarly heterogeneous, each mutated gene has its own genetic and molecular signature. Overall, since the same phenotypes can have multiple causes including different gene mutations, there must be multiple molecular mechanisms causing ALS - and ALS is a syndrome. Since, however, multiple phenotypes can be caused by one single gene mutation, a single molecular mechanism can cause heterogeneity. What the mechanisms are remain unknown, but active propagation of the pathology neuroanatomically seems to be a principal component. Leading candidate mechanisms include RNA processing, cell-cell interactions between neurons and non-neuronal neighbors, focal seeding from a misfolded protein that has prion-like propagation, and fatal errors introduced during neurodevelopment of the motor system. If fundamental mechanisms could be identified and understood, ALS therapy could rationally target progression and stop the disease - a goal that seems increasingly achievable.",
keywords = "ALS, FTD, Motor neuron disease, PLS, PMA",
author = "John Ravits and Stanley Appel and Baloh, {Robert H.} and Richard Barohn and {Rix Brooks}, Benjamin and Lauren Elman and Floeter, {Mary Kay} and Christopher Henderson and Catherine Lomen-Hoerth and MacKlis, {Jeffrey D.} and Leo McCluskey and Hiroshi Mitsumoto and Serge Przedborski and Rothstein, {Jeffrey D} and Trojanowski, {John Q.} and {Van Den Berg}, {Leonard H.} and Steven Ringel",
year = "2013",
month = "5",
doi = "10.3109/21678421.2013.778548",
language = "English (US)",
volume = "14",
pages = "5--18",
journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
issn = "2167-8421",
publisher = "Informa Healthcare",
number = "SUPPL1",

}

TY - JOUR

T1 - Deciphering amyotrophic lateral sclerosis

T2 - What phenotype, neuropathology and genetics are telling us about pathogenesis

AU - Ravits, John

AU - Appel, Stanley

AU - Baloh, Robert H.

AU - Barohn, Richard

AU - Rix Brooks, Benjamin

AU - Elman, Lauren

AU - Floeter, Mary Kay

AU - Henderson, Christopher

AU - Lomen-Hoerth, Catherine

AU - MacKlis, Jeffrey D.

AU - McCluskey, Leo

AU - Mitsumoto, Hiroshi

AU - Przedborski, Serge

AU - Rothstein, Jeffrey D

AU - Trojanowski, John Q.

AU - Van Den Berg, Leonard H.

AU - Ringel, Steven

PY - 2013/5

Y1 - 2013/5

N2 - Amyotrophic lateral sclerosis (ALS) is characterized phenotypically by progressive weakness and neuropathologically by loss of motor neurons. Phenotypically, there is marked heterogeneity. Typical ALS has mixed upper motor neuron (UMN) and lower motor neuron (LMN) involvement. Primary lateral sclerosis has predominant UMN involvement. Progressive muscular atrophy has predominant LMN involvement. Bulbar and limb ALS have predominant regional involvement. Frontotemporal dementia has significant cognitive and behavioral involvement. These phenotypes can be so distinctive that they would seem to have differing biology. However, they cannot be distinguished, at least neuropathologically or genetically. In sporadic ALS (SALS), they are mostly characterized by ubiquitinated cytoplasmic inclusions of TDP-43. In familial ALS (FALS), where phenotypes are indistinguishable from SALS and similarly heterogeneous, each mutated gene has its own genetic and molecular signature. Overall, since the same phenotypes can have multiple causes including different gene mutations, there must be multiple molecular mechanisms causing ALS - and ALS is a syndrome. Since, however, multiple phenotypes can be caused by one single gene mutation, a single molecular mechanism can cause heterogeneity. What the mechanisms are remain unknown, but active propagation of the pathology neuroanatomically seems to be a principal component. Leading candidate mechanisms include RNA processing, cell-cell interactions between neurons and non-neuronal neighbors, focal seeding from a misfolded protein that has prion-like propagation, and fatal errors introduced during neurodevelopment of the motor system. If fundamental mechanisms could be identified and understood, ALS therapy could rationally target progression and stop the disease - a goal that seems increasingly achievable.

AB - Amyotrophic lateral sclerosis (ALS) is characterized phenotypically by progressive weakness and neuropathologically by loss of motor neurons. Phenotypically, there is marked heterogeneity. Typical ALS has mixed upper motor neuron (UMN) and lower motor neuron (LMN) involvement. Primary lateral sclerosis has predominant UMN involvement. Progressive muscular atrophy has predominant LMN involvement. Bulbar and limb ALS have predominant regional involvement. Frontotemporal dementia has significant cognitive and behavioral involvement. These phenotypes can be so distinctive that they would seem to have differing biology. However, they cannot be distinguished, at least neuropathologically or genetically. In sporadic ALS (SALS), they are mostly characterized by ubiquitinated cytoplasmic inclusions of TDP-43. In familial ALS (FALS), where phenotypes are indistinguishable from SALS and similarly heterogeneous, each mutated gene has its own genetic and molecular signature. Overall, since the same phenotypes can have multiple causes including different gene mutations, there must be multiple molecular mechanisms causing ALS - and ALS is a syndrome. Since, however, multiple phenotypes can be caused by one single gene mutation, a single molecular mechanism can cause heterogeneity. What the mechanisms are remain unknown, but active propagation of the pathology neuroanatomically seems to be a principal component. Leading candidate mechanisms include RNA processing, cell-cell interactions between neurons and non-neuronal neighbors, focal seeding from a misfolded protein that has prion-like propagation, and fatal errors introduced during neurodevelopment of the motor system. If fundamental mechanisms could be identified and understood, ALS therapy could rationally target progression and stop the disease - a goal that seems increasingly achievable.

KW - ALS

KW - FTD

KW - Motor neuron disease

KW - PLS

KW - PMA

UR - http://www.scopus.com/inward/record.url?scp=84877871521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877871521&partnerID=8YFLogxK

U2 - 10.3109/21678421.2013.778548

DO - 10.3109/21678421.2013.778548

M3 - Article

VL - 14

SP - 5

EP - 18

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SN - 2167-8421

IS - SUPPL1

ER -